Synthetic buffer composition for clinical use

Details Synthetic buffer composition for clinical use Synthetic buffer composition for clinical use

1992-03-17

1993-10-26

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514255, 514578, A61K 31185, A61K 31495, A61K 31535

Patent

active

052566609

ABSTRACT:
Methods of administering aqueous synthetic buffer compositions of an N-substituted aminosulfonic acid and a sodium salt of a different substituted aminosulfonic acid suitable to treat oligemic, respiratory and metabolic acidosis are disclosed. Methods of administering aqueous synthetic buffer compositions of a different N-substituted aminosulfonic acid, a sodium salt of an N-substituted aminosulfonic acid and tris(hydroxymethyl)aminomethane which may be similarly employed are also disclosed.

REFERENCES:
patent: 4383043 (1983-05-01), Denney et al.
patent: 4548817 (1985-10-01), Filley et al.
Journal of the American Medical Association, Oct. 16, 1991 Issue, pp. 2121-2126, Fulvio Kette, et al., "Buffer Solutions May Compromise Cardiac Resuscitation by Reducing Coronary Perfusion Pressure".
Manzoni et al., Chem Abstracts vol. 113, No. 37387j (1989).
Eagle, Science, vol. 174, pp. 500-503 (1971).
Butler, Ionic Equilibrium: A Mathematical Approach, Addison-Wesley Pub. Co., Inc., (1964), pp. 145-147.
Waters et al., "Spontaneous Lactic Acidosis", Am. J. Med., 1963, 35:781-793.
Kaye, R., "Diabetic Ketoacidosis-The Bicarbonate Controversy", J. Pediat., 1975, 87:156-159.
Luft et al., "Lactic Acidosis in Biguanide-Treated Diabetics: A Review of 330 Cases", Diabetologia, 1978, 14:75-87.
Garella et al., "Severity of Metabolic Acidosis as a Determinate of Bicarbonate Requirements", N. Engl. J. Med., 1973, 289:121-126.
Hazard, P. and J. Griffin, "Calculation of Sodium Bicarbonate Requirement in Metabolic Acidosis", Am. J. Med. Sci., 1982, 18-22.
Ostrea, et al., "The Influence of Bicarbonate Administration on Blood pH in a `Closed System`: Clinical Implications", Fetal Neonat. Med., 1972, 80:671-680.
Arieff et al., "Pathophysiology of Experimental Lactic Acidosis in Dogs", Am. J. Physiol., 1980, 239:F135-142.
Arieff et al., "Systematic Effects of NaHCO.sub.3 in Experimental Lactic Acidosis in Dogs", Am. J. Physiol., 1982, 242:F586-591.
Graf et al., "Metabolic Effects of Sodium Bicarbonate in Hypoxic Lactic Acidosis in Dogs", Am. J. Physiol., 1985, 249:F630-635.
Graf et al., "Evidence for a Detrimentla Effect of Bicarbonate Therapy in Hypoxic Lactic Acidosis", Science, 1985, 227:754-756.
Kindig, N. and G. Filley, "Intravenous Bicarbonate May Cause Transient Intraceullar Acidosis", Chest, 1983, 83:712.
Nahas, G., "The Pharmacology of TRIS (Hydroxymethyl) Aminomethane (THAM)", Pharmacol. Rev., 1982, 14:447-472.
Bleich et al., "TRIS Buffer (THAM) An Appraisal of its Physiologic Effects and Clinical Usefulness", N. Engl. J. Med., 1966, 274:782-787.
Strauss, J., "TRIS (Hydroxymethyl) Amino-Methane (THAM): A Pediatric Evaluation", Pediatrics, 1968, 41:667-689.
Good et al., "Hydrogen Ion Buffers for Biological Research", Biochem., 1966, 5:467-477.
Ferguson et al., "Hydrogen Ion Buffers for Biological Research", Anal. Biochem., 1980, 104:300-310.
Belzer et al., "A New Perfusate For Kidney Preservation", Transplantation, 1982, 33:322-323.
J. S. Gillespie, et al., "Adverse Effects of Tris Hydrochloride, a Commonly Used Buffer in Physiological Media", J. Physiol., 1976, 259:561-73.
S. A. Kaplan, "Tris (Hydroxymethyl) Aminomethane (THAM)-A New Buffer for Therapeutic Use", Am. J. Dis. Child., 1962, 103:1-3.
H. Swan, "Metabolic Rate, Temperature and Acid-Base Control: The Best Strategy and Our Needs to Achieve It", J. Extra-Corporeal Tech., vol. 17(2), pp. 65-73 (1985).
H. Swan, "The Importance of Acid-Base Management for Cardiac and Cerebral Preservation During Open Heart Operations", Surg., Gyn. & Obstet., vol. 158, pp. 391-414 (1984).
Swan, 1984 and H. Swan, "The Hydroxyl-Hydrogen Ion Concentration Ratio During Hypothermia", Surg., Gyn. & Obstet., vol. 155, pp. 897-912 (1982).
H. Swan et al., "A Study of Large Infusions of Bicarbonate Containing Electrolyte Solution", Surg., Gyn. & Obstet., vol. 137, pp. 26-30 (1973).
Durst, R. A. and Staples B. R., "Tris/Tris:HCI: A Standard Buffer for Use in the Physiologic pH Range", Clin. Chem., 1972, 18:206-208.
Chemical Abstracts: vol. 96:195977m (1982), Cui et al.
Chemical Abstracts: vol. 68:46235n (1968), Frackowaik et al.
Biological Abstracts: vol. 82:1963 (1960), Balmaceda et al.
Chemical Abstracts: vol. 104:101284s (1986), Hegetschweisen et al.
Chemical Abstracts: vol. 80:46248s (1974), Husberg.

Affiliated with

Also associated with

Rating

Synthetic buffer composition for clinical use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthetic buffer composition for clinical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic buffer composition for clinical use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-959553